Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: Report from the Turkish Severe Congenital Neutropenia Registry.

Yılmaz Karapınar D, Patıroğlu T, Metin A, Çalışkan Ü, Celkan T, Yılmaz B, Karakaş Z, Karapınar TH, Akıncı B, Özkınay F, Onay H, Yeşilipek MA, Akar HH, Tüysüz G, Tokgöz H, Özdemir GN, Aslan Kıykım A, Karaman S, Kılınç Y, Oymak Y, Küpesiz A, Olcay L, Keskin Yıldırım Z, Aydoğan G, Gökçe M, İleri T, Aral YZ, Bay A, Atabay B, Kaya Z, Söker M, Özdemir Karadaş N, Özbek U, Özsait Selçuk B, Özdemir HH, Uygun V, Tezcan Karasu G, Yılmaz Ş.

Pediatr Blood Cancer. 2019 Oct;66(10):e27923. doi: 10.1002/pbc.27923. Epub 2019 Jul 19.

PMID:
31321910
2.

Integrative Proteo-genomic Analysis to Construct CNA-protein Regulatory Map in Breast and Ovarian Tumors.

Ma W, Chen LS, Özbek U, Han SW, Lin C, Paulovich AG, Zhong H, Wang P.

Mol Cell Proteomics. 2019 Aug 9;18(8 suppl 1):S66-S81. doi: 10.1074/mcp.RA118.001229. Epub 2019 Jul 7.

3.

Prognostic gene alterations and clonal changes in childhood B-ALL.

Erbilgin Y, Firtina S, Mercan S, Hatirnaz Ng O, Karaman S, Tasar O, Karakas Z, Celkan TT, Zengin E, Sarper N, Yildirmak ZY, Sisko S, Ozbek U, Sayitoglu M.

Leuk Res. 2019 Aug;83:106159. doi: 10.1016/j.leukres.2019.05.009. Epub 2019 Jun 8.

PMID:
31228652
4.

The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations.

Soysal T, Eskazan AE, Serin I, Sadri S, Keskin D, Ozgur Yurttas N, Berk S, Erdogan Ozunal I, Salihoglu A, Ar MC, Ongoren S, Baslar Z, Ozbek U, Aydin Y.

Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e377-e384. doi: 10.1016/j.clml.2019.03.028. Epub 2019 Apr 4.

PMID:
31088736
5.

The Role of the Local Bone Marrow Renin-Angiotensin System in Multiple Myeloma

Saka B, Sayitoğlu M, İstemihan Z, Karan MA, Erten N, Doğan Ö, Özbek U, Genç S, Taşçıoğlu C, Kalayoğlu-Beşışık S.

Turk J Haematol. 2019 Aug 2;36(3):178-185. doi: 10.4274/tjh.galenos.2019.2018.0420. Epub 2019 May 1.

6.

Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies.

Smith WH, Luskin I, Resende Salgado L, Scarborough BM, Lin JY, Özbek U, Miles BA, Gupta V, Bakst RL.

Oral Oncol. 2019 May;92:1-5. doi: 10.1016/j.oraloncology.2019.03.007. Epub 2019 Mar 12.

PMID:
31010616
7.

Proteomics profiling of arginine methylation defines PRMT5 substrate specificity.

Musiani D, Bok J, Massignani E, Wu L, Tabaglio T, Ippolito MR, Cuomo A, Ozbek U, Zorgati H, Ghoshdastider U, Robinson RC, Guccione E, Bonaldi T.

Sci Signal. 2019 Apr 2;12(575). pii: eaat8388. doi: 10.1126/scisignal.aat8388.

PMID:
30940768
8.

Biallelic loss of EEF1D function links heat shock response pathway to autosomal recessive intellectual disability.

Ugur Iseri SA, Yucesan E, Tuncer FN, Calik M, Kesim Y, Altiokka Uzun G, Ozbek U.

J Hum Genet. 2019 May;64(5):421-426. doi: 10.1038/s10038-019-0570-z. Epub 2019 Feb 21.

PMID:
30787422
9.

Identification of epilepsy related pathways using genome-wide DNA methylation measures: A trio-based approach.

Ozdemir O, Egemen E, Ugur Iseri SA, Sezerman OU, Bebek N, Baykan B, Ozbek U.

PLoS One. 2019 Feb 8;14(2):e0211917. doi: 10.1371/journal.pone.0211917. eCollection 2019.

10.

Dual Modality Radiation With External Beam Radiation Therapy and Transarterial Radioembolization for Hepatocellular Carcinoma With Gross Vascular Invasion.

McGee HM, King MJ, Özbek U, Olson A, Kim E, Fischman AM, Schwartz M, Rosenzweig KE, Buckstein M.

Am J Clin Oncol. 2019 Apr;42(4):367-374. doi: 10.1097/COC.0000000000000523.

PMID:
30724782
11.

No evidence for a BRD2 promoter hypermethylation in blood leukocytes of Europeans with juvenile myoclonic epilepsy.

Schulz H, Ruppert AK, Zara F, Madia F, Iacomino M, S Vari M, Balagura G, Minetti C, Striano P, Bianchi A, Marini C, Guerrini R, Weber YG, Becker F, Lerche H, Kapser C, Schankin CJ, Kunz WS, Møller RS, Oliver KL, Bellows ST, Mullen SA, Berkovic SF, Scheffer IE, Caglayan H, Ozbek U, Hoffmann P, Schramm S, Tsortouktzidis D, Becker AJ, Sander T.

Epilepsia. 2019 May;60(5):e31-e36. doi: 10.1111/epi.14657. Epub 2019 Feb 4.

PMID:
30719712
12.

A Novel and Mosaic WDR45 Nonsense Variant Causes Beta-Propeller Protein-Associated Neurodegeneration Identified Through Whole Exome Sequencing and X chromosome Heterozygosity Analysis.

Akçakaya NH, Salman B, Görmez Z, Tarkan Argüden Y, Çırakoğlu A, Çakmur R, Dönmez Çolakoğlu B, Hacıhanefioğlu S, Özbek U, Yapıcı Z, Uğur İşeri SA.

Neuromolecular Med. 2019 Mar;21(1):54-59. doi: 10.1007/s12017-018-08522-6. Epub 2019 Jan 5.

PMID:
30612247
13.

Analysis of Local Control and Pain Control After Spine Stereotactic Radiosurgery Reveals Inferior Outcomes for Hepatocellular Carcinoma Compared With Other Radioresistant Histologies.

McGee HM, Carpenter TJ, Ozbek U, Kirkwood KA, Tseng TC, Blacksburg S, Germano IM, Green S, Buckstein M.

Pract Radiat Oncol. 2019 Mar;9(2):89-97. doi: 10.1016/j.prro.2018.11.009. Epub 2018 Dec 10.

PMID:
30543868
14.

Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group.

Aytaç E, Aslan F, Çicek B, Erdamar S, Gürses B, Güven K, Falay O, Karahasanoğlu T, Selçukbiricik F, Selek U, Atalar B, Balık E, Tözün N, Rozanes İ, Arıcan A, Hamzaoğlu İ, Baca B, Molinas Mandel N, Saruç M, Göksel S, Demir G, Ağaoğlu F, Yakıcıer C, Özbek U, Özben V, Özyar E, Güner AL, Er Ö, Kaban K, Bölükbaşı Y, Buğra D, Group Tİ.

Turk J Gastroenterol. 2019 Jul;30(7):584-598. doi: 10.5152/tjg.2018.18737. Review.

15.

Investigation of SLC2A1 gene variants in genetic generalized epilepsy patients with eyelid myoclonia.

Altıokka-Uzun G, Özdemir Ö, Uğur-İşeri S, Bebek N, Gürses C, Özbek U, Baykan B.

Epileptic Disord. 2018 Oct 1;20(5):396-400. doi: 10.1684/epd.2018.0998.

PMID:
30361188
16.

Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation.

Papa L, Zimran E, Djedaini M, Ge Y, Ozbek U, Sebra R, Sealfon SC, Hoffman R.

Blood Adv. 2018 Oct 23;2(20):2766-2779. doi: 10.1182/bloodadvances.2018024273.

17.

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.

Hartwell MJ, Özbek U, Holler E, Renteria AS, Major-Monfried H, Reddy P, Aziz M, Hogan WJ, Ayuk F, Efebera YA, Hexner EO, Bunworasate U, Qayed M, Ordemann R, Wölfl M, Mielke S, Pawarode A, Chen YB, Devine S, Harris AC, Jagasia M, Kitko CL, Litzow MR, Kröger N, Locatelli F, Morales G, Nakamura R, Reshef R, Rösler W, Weber D, Wudhikarn K, Yanik GA, Levine JE, Ferrara JL.

JCI Insight. 2018 Aug 23;3(16). pii: 124015. doi: 10.1172/jci.insight.124015. eCollection 2018 Aug 23. No abstract available.

18.

Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease.

Zhao D, Kim YH, Jeong S, Greenson JK, Chaudhry MS, Hoepting M, Anderson ER, van den Brink MR, Peled JU, Gomes AL, Slingerland AE, Donovan MJ, Harris AC, Levine JE, Ozbek U, Hooper LV, Stappenbeck TS, Ver Heul A, Liu TC, Reddy P, Ferrara JL.

J Clin Invest. 2018 Nov 1;128(11):4970-4979. doi: 10.1172/JCI99261. Epub 2018 Sep 24.

19.

Characterizing functional consequences of DNA copy number alterations in breast and ovarian tumors by spaceMap.

Conley CJ, Ozbek U, Wang P, Peng J.

J Genet Genomics. 2018 Jul 20;45(7):361-371. doi: 10.1016/j.jgg.2018.07.003. Epub 2018 Jul 26.

PMID:
30057342
20.

Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study.

May P, Girard S, Harrer M, Bobbili DR, Schubert J, Wolking S, Becker F, Lachance-Touchette P, Meloche C, Gravel M, Niturad CE, Knaus J, De Kovel C, Toliat M, Polvi A, Iacomino M, Guerrero-López R, Baulac S, Marini C, Thiele H, Altmüller J, Jabbari K, Ruppert AK, Jurkowski W, Lal D, Rusconi R, Cestèle S, Terragni B, Coombs ID, Reid CA, Striano P, Caglayan H, Siren A, Everett K, Møller RS, Hjalgrim H, Muhle H, Helbig I, Kunz WS, Weber YG, Weckhuysen S, Jonghe P, Sisodiya SM, Nabbout R, Franceschetti S, Coppola A, Vari MS, Kasteleijn-Nolst Trenité D, Baykan B, Ozbek U, Bebek N, Klein KM, Rosenow F, Nguyen DK, Dubeau F, Carmant L, Lortie A, Desbiens R, Clément JF, Cieuta-Walti C, Sills GJ, Auce P, Francis B, Johnson MR, Marson AG, Berghuis B, Sander JW, Avbersek A, McCormack M, Cavalleri GL, Delanty N, Depondt C, Krenn M, Zimprich F, Peter S, Nikanorova M, Kraaij R, van Rooij J, Balling R, Ikram MA, Uitterlinden AG, Avanzini G, Schorge S, Petrou S, Mantegazza M, Sander T, LeGuern E, Serratosa JM, Koeleman BPC, Palotie A, Lehesjoki AE, Nothnagel M, Nürnberg P, Maljevic S, Zara F, Cossette P, Krause R, Lerche H; Epicure Consortium; EuroEPINOMICS CoGIE Consortium; EpiPGX Consortium.

Lancet Neurol. 2018 Aug;17(8):699-708. doi: 10.1016/S1474-4422(18)30215-1. Epub 2018 Jul 17.

21.

Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up.

Saydam G, Haznedaroglu IC, Kaynar L, Yavuz AS, Ali R, Guvenc B, Akay OM, Baslar Z, Ozbek U, Sonmez M, Aydin D, Pehlivan M, Undar B, Dagdas S, Ayyildiz O, Akin G, Dag IM, Ilhan O.

Hematology. 2018 Dec;23(10):771-777. doi: 10.1080/10245332.2018.1498167. Epub 2018 Jul 11.

PMID:
29996726
22.

Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.

Erbilgin Y, Eskazan AE, Hatirnaz Ng O, Salihoglu A, Elverdi T, Firtina S, Tasar O, Mercan S, Sisko S, Khodzhaev K, Ongoren S, Ar MC, Baslar Z, Soysal T, Sayitoglu M, Ozbek U.

Leuk Lymphoma. 2019 Jan;60(1):200-207. doi: 10.1080/10428194.2018.1473573. Epub 2018 Jul 2.

PMID:
29965782
23.

Statistics for X-chromosome associations.

Özbek U, Lin HM, Lin Y, Weeks DE, Chen W, Shaffer JR, Purcell SM, Feingold E.

Genet Epidemiol. 2018 Sep;42(6):539-550. doi: 10.1002/gepi.22132. Epub 2018 Jun 13.

24.

Ten Essential Practices for Developing or Reforming a Biostatistics Core for a NCI Designated Cancer Center.

Mazumdar M, Moshier EL, Özbek U, Parsons R.

JNCI Cancer Spectr. 2018 Apr 28;2(1):pky010. doi: 10.1093/jncics/pky010. eCollection 2018 Jan. Review. Erratum in: JNCI Cancer Spectr. 2018 Jul 30;2(3):pky040.

25.

Association of Pro-apoptotic Bad Gene Expression Changes with Benign Thyroid Nodules.

Gül N, Temel B, Ustek D, Sirma-Ekmekçi S, Kapran Y, Tunca F, Giles-Şenyürek Y, Özbek U, Alagöl F.

In Vivo. 2018 May-Jun;32(3):555-559.

26.

Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States.

De B, Rhome R, Jairam V, Özbek U, Holcombe RF, Buckstein M, Ang C.

Gastric Cancer. 2018 Nov;21(6):889-899. doi: 10.1007/s10120-018-0826-x. Epub 2018 Apr 24.

PMID:
29691758
27.

MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.

Major-Monfried H, Renteria AS, Pawarode A, Reddy P, Ayuk F, Holler E, Efebera YA, Hogan WJ, Wölfl M, Qayed M, Hexner EO, Wudhikarn K, Ordemann R, Young R, Shah J, Hartwell MJ, Chaudhry MS, Aziz M, Etra A, Yanik GA, Kröger N, Weber D, Chen YB, Nakamura R, Rösler W, Kitko CL, Harris AC, Pulsipher M, Reshef R, Kowalyk S, Morales G, Torres I, Özbek U, Ferrara JLM, Levine JE.

Blood. 2018 Jun 21;131(25):2846-2855. doi: 10.1182/blood-2018-01-822957. Epub 2018 Mar 15.

28.

Clinical phenotype of hereditary spastic paraplegia due to KIF1C gene mutations across life span.

Yücel-Yılmaz D, Yücesan E, Yalnızoğlu D, Oğuz KK, Sağıroğlu MŞ, Özbek U, Serdaroğlu E, Bilgiç B, Erdem S, İşeri SAU, Hanağası H, Gürvit H, Özgül RK, Dursun A.

Brain Dev. 2018 Jun;40(6):458-464. doi: 10.1016/j.braindev.2018.02.013. Epub 2018 Mar 12.

PMID:
29544888
29.

Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

Saydam G, Haznedaroglu IC, Kaynar L, Yavuz AS, Ali R, Guvenc B, Akay OM, Baslar Z, Ozbek U, Sonmez M, Aydin D, Pehlivan M, Undar B, Dagdas S, Ayyildiz O, Akkaynak DZ, Akin G, İlhan O.

Hematology. 2018 Feb 27:1-7. doi: 10.1080/10245332.2018.1444919. [Epub ahead of print] Retraction in: Hematology. 2018 Oct;23(9):720.

PMID:
29486663
30.

The Prevalence of Extranodal Extension in Papillary Thyroid Cancer Based on the Size of the Metastatic Node: Adverse Histologic Features Are Not Limited to Larger Lymph Nodes.

Rowe ME, Ozbek U, Machado RA, Yue LE, Hernandez-Prera JC, Valentino A, Qazi M, Brandwein-Weber M, Liu X, Wenig BM, Urken ML.

Endocr Pathol. 2018 Mar;29(1):80-85. doi: 10.1007/s12022-018-9518-7.

PMID:
29396810
31.

In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation.

Pidala J, Beato F, Kim J, Betts B, Jim H, Sagatys E, Levine JE, Ferrara JLM, Ozbek U, Ayala E, Davila M, Fernandez HF, Field T, Kharfan-Dabaja MA, Khaira D, Khimani F, Locke FL, Mishra A, Nieder M, Nishihori T, Perez L, Riches M, Anasetti C.

Haematologica. 2018 Mar;103(3):531-539. doi: 10.3324/haematol.2017.171199. Epub 2017 Dec 14.

32.

Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.

Ongoren S, Eskazan AE, Suzan V, Savci S, Erdogan Ozunal I, Berk S, Yalniz FF, Elverdi T, Salihoglu A, Erbilgin Y, Iseri SA, Ar MC, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Hematology. 2018 May;23(4):212-220. doi: 10.1080/10245332.2017.1385193. Epub 2017 Oct 9. Review.

PMID:
28990873
33.

What has GWAS done for HLA and disease associations?

Kennedy AE, Ozbek U, Dorak MT.

Int J Immunogenet. 2017 Oct;44(5):195-211. doi: 10.1111/iji.12332. Review.

PMID:
28877428
34.

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec.

Eskazan AE, Sadri S, Keskin D, Ayer M, Kantarcioglu B, Demirel N, Aydin D, Aydinli F, Yokus O, Ozunal IE, Berk S, Yalniz FF, Elverdi T, Salihoglu A, Ar MC, Ongoren S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):804-811. doi: 10.1016/j.clml.2017.07.255. Epub 2017 Aug 4.

PMID:
28847475
35.

Prognostic significance of Kadish staging in esthesioneuroblastoma: An analysis of the National Cancer Database.

Konuthula N, Iloreta AM, Miles B, Rhome R, Ozbek U, Genden EM, Posner M, Misiukiewicz K, Govindaraj S, Shrivastava R, Gupta V, Bakst RL.

Head Neck. 2017 Oct;39(10):1962-1968. doi: 10.1002/hed.24770. Epub 2017 Aug 17.

36.

Combined association of Presenilin-1 and Apolipoprotein E polymorphisms with maternal meiosis II error in Down syndrome births.

Bhaumik P, Ghosh P, Ghosh S, Feingold E, Ozbek U, Sarkar B, Dey SK.

Genet Mol Biol. 2017 Jul-Sep;40(3):577-585. doi: 10.1590/1678-4685-GMB-2016-0138. Epub 2017 Jul 31.

37.

Adjuvant radiation for salivary gland malignancies is associated with improved survival: A National Cancer Database analysis.

Bakst RL, Su W, Ozbek U, Knoll MA, Miles BA, Gupta V, Rhome R.

Adv Radiat Oncol. 2017 Apr 6;2(2):159-166. doi: 10.1016/j.adro.2017.03.008. eCollection 2017 Apr-Jun.

38.

Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer.

Kolb JM, Ozbek U, Harpaz N, Holcombe RF, Ang C.

J Gastrointest Oncol. 2017 Jun;8(3):583-588. doi: 10.21037/jgo.2017.01.22.

39.

The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer.

Dave E, Ozbek U, Gupta V, Genden E, Miles B, Teng M, Posner M, Misiukiewicz K, Bakst RL.

PLoS One. 2017 Jul 21;12(7):e0181108. doi: 10.1371/journal.pone.0181108. eCollection 2017.

40.

SYNE1 related cerebellar ataxia presents with variable phenotypes in a consanguineous family from Turkey.

Yucesan E, Ugur Iseri SA, Bilgic B, Gormez Z, Bakir Gungor B, Sarac A, Ozdemir O, Sagiroglu M, Gurvit H, Hanagasi H, Ozbek U.

Neurol Sci. 2017 Dec;38(12):2203-2207. doi: 10.1007/s10072-017-3049-8. Epub 2017 Jul 7.

PMID:
28687974
41.

A novel pathogenic frameshift variant of CD3E gene in two T-B+ NK+ SCID patients from Turkey.

Firtina S, Ng YY, Ng OH, Nepesov S, Yesilbas O, Kilercik M, Burtecene N, Cinar S, Camcioglu Y, Ozbek U, Sayitoglu M.

Immunogenetics. 2017 Oct;69(10):653-659. doi: 10.1007/s00251-017-1005-7. Epub 2017 Jun 9.

PMID:
28597365
42.

Dysregulation of the DKK1 gene in pediatric B-cell acute lymphoblastic leukemia.

Firtina S, Hatirnaz Ng Ö, Erbilgin Y, Özbek U, Sayitoğlu M.

Turk J Med Sci. 2017 Feb 27;47(1):357-363. doi: 10.3906/sag-1507-106.

PMID:
28263515
43.

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.

Hartwell MJ, Özbek U, Holler E, Renteria AS, Major-Monfried H, Reddy P, Aziz M, Hogan WJ, Ayuk F, Efebera YA, Hexner EO, Bunworasate U, Qayed M, Ordemann R, Wölfl M, Mielke S, Pawarode A, Chen YB, Devine S, Harris AC, Jagasia M, Kitko CL, Litzow MR, Kröger N, Locatelli F, Morales G, Nakamura R, Reshef R, Rösler W, Weber D, Wudhikarn K, Yanik GA, Levine JE, Ferrara JL.

JCI Insight. 2017 Feb 9;2(3):e89798. doi: 10.1172/jci.insight.89798. Erratum in: JCI Insight. 2018 Aug 23;3(16):.

44.

Clinical and genetic features of PKAN patients in a tertiary centre in Turkey.

Akcakaya NH, Iseri SU, Bilir B, Battaloglu E, Tekturk P, Gultekin M, Akar G, Yigiter R, Hanagasi H, Alp R, Cagirici S, Eraksoy M, Ozbek U, Yapici Z.

Clin Neurol Neurosurg. 2017 Mar;154:34-42. doi: 10.1016/j.clineuro.2017.01.011. Epub 2017 Jan 15.

PMID:
28113101
45.

Safety of transoral surgery for oropharyngeal malignancies: An analysis of the ACS NSQIP.

Su HK, Ozbek U, Likhterov I, Brant J, Genden EM, Urken ML, Chai RL.

Laryngoscope. 2016 Nov;126(11):2484-2491. doi: 10.1002/lary.26024. Epub 2016 May 31.

PMID:
27242214
46.

Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.

Axelrad J, Kriplani A, Ozbek U, Harpaz N, Colombel JF, Itzkowitz S, Holcombe RF, Ang C.

Clin Colorectal Cancer. 2017 Sep;16(3):e205-e210. doi: 10.1016/j.clcc.2016.09.005. Epub 2016 Sep 20.

47.

The impact of peripheral nerve blocks on perioperative outcome in hip and knee arthroplasty-a population-based study.

Memtsoudis SG, Poeran J, Cozowicz C, Zubizarreta N, Ozbek U, Mazumdar M.

Pain. 2016 Oct;157(10):2341-9. doi: 10.1097/j.pain.0000000000000654.

PMID:
27643835
48.

Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

Saydam G, Haznedaroglu IC, Kaynar L, Yavuz AS, Ali R, Guvenc B, Akay OM, Baslar Z, Ozbek U, Sonmez M, Aydin D, Pehlivan M, Undar B, Dagdas S, Ayyildiz O, Akkaynak DZ, Dag IM, Ilhan O.

Expert Opin Pharmacother. 2016 Oct;17(14):1851-8. doi: 10.1080/14656566.2016.1219338. Epub 2016 Aug 18.

PMID:
27501474
49.

The frequency of C609T polymorphism in the NQO1 gene and its relation to cytogenetic abnormalities in patients with myelodysplastic syndrome.

Bagatir G, Sirma S, Palanduz S, Ozturk S, Cefle K, Ozbek U, Yenerel M, Nalcaci M.

Cell Mol Biol (Noisy-le-grand). 2016 Jun 30;62(7):61-5.

PMID:
27453274
50.

A novel gene mutation in PANK2 in a patient with severe jaw-opening dystonia.

Yapici Z, Akcakaya NH, Tekturk P, Iseri SA, Ozbek U.

Brain Dev. 2016 Sep;38(8):755-8. doi: 10.1016/j.braindev.2016.02.010. Epub 2016 May 13.

PMID:
27185474

Supplemental Content

Support Center